Human VEGF-A Monoclonal Antibody
Produktgrößen
1 mg
£355,00
YR0135-1MG
5 mg
£885,00
YR0135-5MG
20 mg
£2835,00
YR0135-20MG
Über dieses Produkt
- SKU:
- YR0135
- Zusätzliche Namen:
- L-VEGF|MVCD1|VEGF|VPF
- Anwendung:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Klonalität:
- Monoclonal
- Weitere Details:
- Brolucizumab is a monoclonal antibody indicated to treat neovascular age related macular degeneration. Brolucizumab is a vascular endothelial growth factor (VEGF) inhibitor which targets the major VEGF-A isoforms: VEGF110, VEGF121, and VEGF165. Inhibition of these VEGF-A isoforms reduce proliferation of endothelial cells, vascularization of the tissue, and permeability of the vasculature.
- Formulierung:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- Human VEGF-A
- Isotyp:
- IgG1, kappa
- Molekulargewicht:
- 150 kDa
- Reinheit:
- >95%
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- ABclonal Technology
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:YR0135